Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The Worst thing about Brian's resignation

While I don't disagree that at some point an RS may be the ticket for PTSC, I'd MUCH prefer that RG find an M&A target that is already listed on the NAS, and execute on a deal that is structured in a way that the resultant company has listed shares, that properly value our PTSC shares even if they are converted to new shares or the other company's shares.

Do you believe that any potential M&A target, a listed company with shareholders, will value the shares any higher than the current share price?

Be well

Share
New Message
Please login to post a reply